Dolby Laboratories
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $346,706 | $307,024 | $315,546 | $369,561 |
Gross Profit | 303,498 | 267,505 | 271,544 | 333,724 |
EBITDA | 102,533 | 60,380 | 71,490 | 144,677 |
EBIT | 75,720 | 35,805 | 47,092 | 120,250 |
Net Income | 53,327 | 49,332 | 46,071 | 91,793 |
Net Change In Cash | 346,706 | 307,024 | 315,546 | 369,561 |
Free Cash Flow | 49,421 | 100,994 | 61,263 | 168,000 |
Cash | 643,845 | 701,893 | 698,566 | 750,342 |
Basic Shares | 96,518 | 96,846 | 96,900 | 97,471 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $1,349,130 | $1,273,721 | $1,009,182 | $1,253,793 |
Gross Profit | 1,188,998 | 1,133,225 | 892,168 | 1,112,433 |
EBITDA | 378,563 | 399,806 | 219,247 | 318,888 |
EBIT | 279,966 | 312,479 | 219,247 | 215,279 |
Net Income | 255,018 | 261,825 | 191,470 | 184,087 |
Net Change In Cash | 1,349,130 | 1,273,721 | 1,009,182 | 1,253,793 |
Cost of Revenue | -587,917 | |||
Free Cash Flow | 430,257 | 297,245 | 259,912 | 259,120 |
Cash | 701,893 | 577,752 | 817,966 | 628,371 |
Basic Shares | 97,479 | 97,325 | 97,588 | 101,983 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $1.06 |
2025-09-30 | $0.99 |
2025-06-30 | $0.78 |
